Skip to main content
. 2023 Dec 22;44(1):23. doi: 10.1007/s10875-023-01615-3

Table 2.

NTM site of infection and related species

Infection sites Number of patients affected for each species/number of total cases

Pulmonary

[20, 21, 25, 29, 32, 33, 35, 36, 38, 40, 41, 44, 48, 49, 59, 62, 6668, 76]

77/175 (44%)

MAC, 18

M. abscessus, 10

M. chelonae, 8

M. haemophilum, 8

M. fortuitum, 6

M. xenopi, 4

M. kansasii, 2

M. fortuitum and M. chelonae, 1

M. massiliense, 1

M. scrofulaceum, 1

MAC and M. gordonae, 1

Unclassified, 17

Cutaneous

[20, 24, 26, 31, 32, 37, 4143, 45, 46, 5052, 55, 58, 61, 63, 71, 76]

43/175 (24.6%)

M. haemophilum, 29

M. chelonae, 4

M. fortuitum, 3

M. kansasii, 2

M. abscessus, 1

M. marinum, 1

M. massiliense, 1

M. szulgai, 1

MAC, 1

Disseminated

[20, 26, 29, 31, 32, 36, 38, 40, 42, 47, 53, 57, 59, 64, 69, 7274, 76]

38/175 (21.7%)

M. mucogenicum, 8

M. fortuitum, 5

M. haemophilum, 5

MAC, 4

M. chelonae, 4

M. immunogenum, 4

M. abscessus, 3

M. fortuitum and M. haemophilum, 1

M. genavense, 1

M. gordonae, 1

M. massiliense, 1

MAC and M. haemophilum, 1

Others

[29, 31, 35, 39, 54, 56, 59, 60, 65, 70, 74, 76]

15/175 (8.6%)

MAC, 4

M. chelonae, 4

M. haemophilum, 2

M. abscessus, 1

M. genavense, 1

M. neoaurum, 1

Unclassified, 2

Musculoskeletals

[35, 75]

2/175 (1.1%)

M. kansasii, 2

M. mycobacterium, MAC Mycobacterium avium complex